196 related articles for article (PubMed ID: 19648882)
21. Type B3 thymic epithelial tumor in an adolescent detected by immunohistochemical staining for CD5, CD99, and KIT (CD117): a case report.
Yoshino N; Kubokura H; Yamauchi S; Oaki Y; Koizumi K; Shimizu K
Ann Thorac Cardiovasc Surg; 2009 Oct; 15(5):324-7. PubMed ID: 19901887
[TBL] [Abstract][Full Text] [Related]
22. MUC1 expression in thymic epithelial tumors: MUC1 may be useful marker as differential diagnosis between type B3 thymoma and thymic carcinoma.
Kaira K; Murakami H; Serizawa M; Koh Y; Abe M; Ohde Y; Takahashi T; Kondo H; Nakajima T; Yamamoto N
Virchows Arch; 2011 May; 458(5):615-20. PubMed ID: 21253760
[TBL] [Abstract][Full Text] [Related]
23. Expression of PD-1 and PD-L1 in thymic epithelial neoplasms.
Weissferdt A; Fujimoto J; Kalhor N; Rodriguez J; Bassett R; Wistuba II; Moran CA
Mod Pathol; 2017 Jun; 30(6):826-833. PubMed ID: 28281549
[TBL] [Abstract][Full Text] [Related]
24. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
[TBL] [Abstract][Full Text] [Related]
25. Tyrosine kinase receptor expression in thymomas.
Henley JD; Cummings OW; Loehrer PJ
J Cancer Res Clin Oncol; 2004 Apr; 130(4):222-4. PubMed ID: 14762710
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic utility of thymic epithelial markers CD205 (DEC205) and Foxn1 in thymic epithelial neoplasms.
Nonaka D; Henley JD; Chiriboga L; Yee H
Am J Surg Pathol; 2007 Jul; 31(7):1038-44. PubMed ID: 17592270
[TBL] [Abstract][Full Text] [Related]
27. Immunoreactivity of a new CD5 antibody with normal epithelium and malignant tumors including thymic carcinoma.
Tateyama H; Eimoto T; Tada T; Hattori H; Murase T; Takino H
Am J Clin Pathol; 1999 Feb; 111(2):235-40. PubMed ID: 9930146
[TBL] [Abstract][Full Text] [Related]
28. Ectopic thymic carcinoma presenting as an intrathoracic mass.
Matsuoka K; Murata Y; Ueda M; Miyamoto Y
Asian Cardiovasc Thorac Ann; 2016 Jun; 24(5):480-3. PubMed ID: 27072863
[TBL] [Abstract][Full Text] [Related]
29. Difference in distribution profiles between CD163+ tumor-associated macrophages and S100+ dendritic cells in thymic epithelial tumors.
Omatsu M; Kunimura T; Mikogami T; Shiokawa A; Nagai T; Masunaga A; Kitami A; Suzuki T; Kadokura M
Diagn Pathol; 2014 Dec; 9():215. PubMed ID: 25499804
[TBL] [Abstract][Full Text] [Related]
30. The MIC2 antibody 013. Practical application for the study of thymic epithelial tumors.
Chan JK; Tsang WY; Seneviratne S; Pau MY
Am J Surg Pathol; 1995 Oct; 19(10):1115-23. PubMed ID: 7573670
[TBL] [Abstract][Full Text] [Related]
31. Flow cytometric analysis of lymphoid cells in thymic epithelial neoplasms.
Nakajima J; Takamoto S; Oka T; Tanaka M; Takeuchi E; Murakawa T
Eur J Cardiothorac Surg; 2000 Sep; 18(3):287-92. PubMed ID: 10973537
[TBL] [Abstract][Full Text] [Related]
32. Vascular architecture as a diagnostic marker for differentiation of World Health Organization thymoma subtypes and thymic carcinoma.
Pfister F; Hussain H; Belharazem D; Busch S; Simon-Keller K; Becker D; Pfister E; Rieker R; Ströbel P; Marx A
Histopathology; 2017 Apr; 70(5):693-703. PubMed ID: 27791295
[TBL] [Abstract][Full Text] [Related]
33. Carcinoma showing thymus-like differentiation of the thyroid (CASTLE): a comparative study: evidence of thymic differentiation and solid cell nest origin.
Reimann JD; Dorfman DM; Nosé V
Am J Surg Pathol; 2006 Aug; 30(8):994-1001. PubMed ID: 16861971
[TBL] [Abstract][Full Text] [Related]
34. Thymoma with loss of keratin expression (and giant cells): a potential diagnostic pitfall.
Adam P; Hakroush S; Hofmann I; Reidenbach S; Marx A; Ströbel P
Virchows Arch; 2014 Sep; 465(3):313-20. PubMed ID: 24923897
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical markers in the differentiation of thymic and pulmonary neoplasms.
Pomplun S; Wotherspoon AC; Shah G; Goldstraw P; Ladas G; Nicholson AG
Histopathology; 2002 Feb; 40(2):152-8. PubMed ID: 11952859
[TBL] [Abstract][Full Text] [Related]
36. Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma.
Hishima T; Fukayama M; Hayashi Y; Fujii T; Arai K; Shiozawa Y; Funata N; Koike M
Hum Pathol; 1998 Apr; 29(4):330-8. PubMed ID: 9563781
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical staining for bcl-2 and mcl-1 in intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) and cervical thymic carcinoma.
Dorfman DM; Shahsafaei A; Miyauchi A
Mod Pathol; 1998 Oct; 11(10):989-94. PubMed ID: 9796728
[TBL] [Abstract][Full Text] [Related]
38. Detection of bcl-2 and p53 in thymoma: expression of bcl-2 as a reliable marker of tumor aggressiveness.
Chen FF; Yan JJ; Jin YT; Su IJ
Hum Pathol; 1996 Oct; 27(10):1089-92. PubMed ID: 8892596
[TBL] [Abstract][Full Text] [Related]
39. Preferentially expressed antigen in melanoma as a novel diagnostic marker differentiating thymic squamous cell carcinoma from thymoma.
Taniguchi Y; Ishida M; Saito T; Ryota H; Utsumi T; Maru N; Matsui H; Hino H; Tsuta K; Murakawa T
Sci Rep; 2020 Jul; 10(1):12286. PubMed ID: 32704057
[TBL] [Abstract][Full Text] [Related]
40. Cytokeratins in normal thymus and thymic epithelial tumors.
Fukai I; Masaoka A; Hashimoto T; Yamakawa Y; Mizuno T; Tanamura O
Cancer; 1993 Jan; 71(1):99-105. PubMed ID: 7677978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
